Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fudan University
Xencor, Inc.
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Mannkind Corporation